Cited by 620Systemic Lupus Erythematosus ResearchReproductive System and PregnancyBlood Coagulation and Thrombosis Mechanisms

The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

Meroni, Pier Luigi, Borghi, M. Orietta, Raschi, Elena, Tedesco, Francesco·2011·Nature Reviews Rheumatology

DOI 10.1038/nrrheum.2011.52

Open this paper in CoChat — free account

Abstract

Antiphospholipid antibodies (aPL) are both diagnostic markers for, and pathogenic drivers of, antiphospholipid syndrome (APS). Although the presence of aPL is a necessary pre-condition, APS-associated clotting is seemingly triggered by an additional 'second hit', frequently related to innate inflammatory immune responses. β(2) glycoprotein I (β(2)GPI)-dependent aPL, the most important subset of these antibodies, mediate several--not necessarily alternative--thrombogenic mechanisms, mainly on the basis of their reactivity with β(2)GPI expressed on the membrane of cells that participate in the coagulation cascade. Recurrent pregnancy complications associated with aPL cannot be explained solely by thrombosis, and alternative pathogenic mechanisms have been reported. Although one in vivo model of fetal loss suggests a mechanism of aPL-mediated acute placental inflammation, other models and the histopathological examination of APS placentae do not support a widespread inflammatory signature. β(2)GPI-dependent aPL are thought to recognize their antigen on placental tissues, inhibit the growth and differentiation of trophoblasts, and eventually cause defective placentation. Why antibodies with similar antigen specificity produce different clinical manifestations is not clear. Characterization of the molecular basis of the pathogenic mechanisms involved, including the putative second hits and the role of complement activation, might offer an answer to this question.

Integrity signals

Registry

Crossref · 10.1038/nrrheum.2011.52

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Self-citation
Antiphospholipid syndrome
Ruiz‐Irastorza, G., Crowther, M. A., Branch, W. D., & Khamashta, M. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60709-x · Cited by 875
Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits
Tang, S.-C., Arumugam, T. V., Xu, X., Cheng, A., Mughal, M. R., Jo, D. G., Lathia, J. D., Siler, D. A., Chigurupati, S., Ouyang, X., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702553104 · Cited by 779
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P. B., Spruce, L. A., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18817 · Cited by 691
Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation
Girardi, G., Redecha, P. B., & Salmon, J. E. (2004) · Nature Medicine · doi:10.1038/nm1121 · Cited by 680
Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
Holers, V. M., Girardi, G., Mo, L., Guthridge, J. M., Molina, H. D., Pierangeli, S. S., Espinola, R. G., Xiaowei, L. E., Mao, D., Vialpando, C. G., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.200116116 · Cited by 625
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P. B., Spruce, L. A., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318817 · Cited by 593
Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment
Cowchock, F. S., Reece, E. A., Balaban, D. J., Branch, D. W., & Plouffe, L. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91596-3 · Cited by 585
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction
Girardi, G., Yarilin, D. A., Thurman, J. M., Holers, V. M., & Salmon, J. E. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061022 · Cited by 509
Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome
Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-11-3334 · Cited by 413

Flagged first, then by citations

Show all 89 references

Research works printed but not linked: 5

Gerosa, M. et al. Complement involvement in antiphospholipid-mediated placental damage: prospective study in APS pregnant women [abstract THU0120] Ann. Rheum. Dis. 68 (Suppl. 3), 210 (2009).
Borghi, M. O. et al. Antiphospholipid antibodies reactivity with human decidual cells: an additional mechanism of pregnancy complications in APS and a potential target for innovative therapeutic intervention [abstract OP-0119]. Ann. Rheum. Dis. 68 (Suppl. 3), 109 (2009).
Raschi, E., Broggini, V., Borghi, M. O., Grossi, C. & Meroni, P. L. TLR-4 and Annexin A2 involvement in endothelial cell activation by anti-phospholipid antibodies: specific silencing by small interfering RNAs [abstract 1356]. Arthritis Rheum. 62 (Suppl.), S563 (2010).
Tedesco, F. Biodistribution of β2GPI in naive and immunized mice and in vivo pro-thrombotic effect of an anti-β2GPI minibody isolated from human phage display library [abstract A006]. Lupus 19, 497–498 (2010).
Ziglioli, T. et al. Low complement levels during pregnancy are associated with obstetric complications in patients with primary antiphospholipid syndrome [abstract THU0129]. Ann. Rheum. Dis. 68 (Suppl. 3), 213–214 (2009).

Sorted by citations

Items 301–400 of 620

Phospholipid-binding proteins differ in their capacity to induce autoantibodies and murine systemic lupus erythematosus
Levine, J. S., Subang, R., Setty, S., Cabrera, J., Laplante, P., Fritzler, M. J., & Rauch, J. (2014) · Lupus · doi:10.1177/0961203314525676 · Cited by 13
Detection of multiple annexin autoantibodies in a patient with recurrent miscarriages, fulminant stroke and seronegative antiphospholipid syndrome
Scholz, P., Auler, M. M. K., Brachvogel, B., Benzing, T. R., Mallman, P., Streichert, T., & Klatt, A. R. (2016) · Biochemia Medica · doi:10.11613/bm.2016.032 · Cited by 13
Role of β2‐glycoprotein I in the pathogenesis of the antiphospholipid syndrome
Li, J., Zhu, X., & Feng, J. (2023) · Rheumatology & autoimmunity · doi:10.1002/rai2.12072 · Cited by 12
Dendritic Cells and Antiphospholipid Syndrome: An Updated Systematic Review
Tang, K., Chen, H., Chen, T., Bracci, N. R., & Lin, C. (2021) · Life · doi:10.3390/life11080801 · Cited by 12
“True” Antiphospholipid Syndrome in COVID-19: Contribution of the Follow-up of Antiphospholipid Autoantibodies
Arcani, R., Cauchois, R., Suchon, P., Weber, S., Jean, R., Jarrot, P., Rey, L., Venton, G., Koubi, M., Muller, R., et al. (2022) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0042-1758118 · Cited by 12
Antiphospholipid antibody-mediated NK cell cytotoxicity
Manukyan, G. P., Kriegová, E., Slavík, L., Mikulková, Z., Úlehlová, J., Martirosyan, A., & Papajík, T. (2022) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2022.103791 · Cited by 12
Phospholipid scramblase 1 expression is enhanced in patients with antiphospholipid syndrome
Amengual, O., Atsumi, T., Oku, K., Suzuki, E., Horita, T., Yasuda, S., & Koike, T. (2012) · Modern Rheumatology · doi:10.1007/s10165-012-0642-9 · Cited by 12
Early mortality after heart transplantation related to IgA anti–β2-glycoprotein I antibodies
Delgado, J. F., Serrano, M., Morán-Fernández, L., Enguita, A. B., Martínez-Flores, J. A., Ortiz‐Bautista, C., Rodríguez-Chaverri, A., de Antonio, I. P., Carmena, M. D. G., Castro-Panete, M. J., et al. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.05.016 · Cited by 12
Autoantibody profiling in APS
Roggenbuck, D., Somma, V., Schierack, P., Borghi, M. O., & Meroni, P. L. (2014) · Lupus · doi:10.1177/0961203314534305 · Cited by 12
Self-citation
Biomarkers for cardiovascular risk assessment in autoimmune diseases
Teixeira, P. C., Ferber, P. C., Vuilleumier, N., & Cutler, P. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400125 · Cited by 11
Pathogenicity and Virulence of Coxiella burnetii: Focus on Q fever
Mezouar, S., Desnues, B., Bechah, Y., Bardin, N., Devaux, C. A., & Mège, J. (2025) · Virulence · doi:10.1080/21505594.2025.2495842 · Cited by 11
Interpretation of autoantibodies in rheumatological diseases
Méndez‐Rayo, T., Ochoa-Zárate, L., Posso‐Osorio, I., Ortíz, E., Naranjo-Escobar, J., & Tobón, G. J. (2018) · Revista Colombiana de Reumatología (English Edition) · doi:10.1016/j.rcreue.2019.01.001 · Cited by 11
Association between antiphospholipid antibodies and all-cause mortality among end-stage renal disease patients with and without SLE: a retrospective cohort study
Broder, A. R., Mowrey, W. B., Kim, M., Murakhovskaya, I., Billett, H. H., Neugarten, J., Costenbader, K. H., & Putterman, C. (2015) · Rheumatology · doi:10.1093/rheumatology/kev423 · Cited by 11
Is there a link between mean platelet volume and thrombotic events in antiphospholipid syndrome?
Korkmaz, S., Uslu, A. U., Şahin, Ş., Şenel, S., & Şencan, M. (2013) · Platelets · doi:10.3109/09537104.2013.824563 · Cited by 11
Mitigating placental injuries through up-regulating DAF in experimental APS mice: new mechanism of progesterone
Zhang, Y., & Jin, S. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13313 · Cited by 11
Pathophysiology of the antiphospholipid syndrome (APS)
Meroni, P. L., & Chighizola, C. B. (2012) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.09.010 · Cited by 11
Self-citation
Antiphospholipid Syndrome
Bhasin, N., Knoll, C. M., & Skeith, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-48446-0_24 · Cited by 11
Serum Protein Profile in Women With Pregnancy Morbidity Associated With Antiphospholipid Syndrome.
Álvarez, Á. M., Neubeck, S., Parra, S., Markert, U. R., & Cadavid, Á. P. (2017) · Europe PMC (PubMed Central) · doi:10.4103/0974-1208.204018 · Cited by 11
Antiphospholipid Syndrome
Wysokinska, E. M., & Ortel, T. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-46202-0.00020-0 · Cited by 11
Antiphospholipid antibodies and cardiovascular thrombosis
Rashedi, S., Leyva, H., Siddiqui, S. A., Bukhari, S., Pfeferman, M. B., Watson, N. W., Ujueta, F., Zarghami, M., Bacare, B., Kanthi, Y. M., et al. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01269-9 · Cited by 10
Isolated cerebral sinovenous thrombosis: a rare case of neonatal antiphospholipid syndrome.
Carolis, M. P. D., Salvi, S., Bersani, I., & Carolis, S. D. (2012) · PubMed · Cited by 10
Oxidative Stress as a Regulatory Checkpoint in the Production of Antiphospholipid Autoantibodies: The Protective Role of NRF2 Pathway
Sorice, M., Profumo, E., Capozzi, A., Recalchi, S., Riitano, G., Veroli, B. D., Saso, L., & Buttari, B. (2023) · Biomolecules · doi:10.3390/biom13081221 · Cited by 10
Clinical and Laboratory Diagnosis of Antiphospholipid Syndrome: A Review
Zahidin, M. A., Iberahim, S., Hassan, M. N., Zulkafli, Z. B., & Noor, N. H. M. (2024) · Cureus · doi:10.7759/cureus.61713 · Cited by 10
Biological markers of high risk of thrombotic recurrence in patients with antiphospholipid syndrome: A literature review
Lambert, M., Brodovitch, A., Mège, J., Bertin, D., & Bardin, N. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103585 · Cited by 10
Defective germinal center selection results in persistence of self-reactive B cells from the primary to the secondary repertoire in Primary Antiphospholipid Syndrome
Dieudonné, Y., Lorenzetti, R., Rottura, J., Janowska, I., Frenger, Q., Jacquel, L., Vollmer, O., Carbone, F., Zhu, C., Luka, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54228-8 · Cited by 10
ABO blood group in primary antiphospholipid syndrome: influence in the site of thrombosis?
Nascimento, N. M., Bydlowski, S. P., Soares, R. P. S., ANDRADE, D. C. O. D., Bonfá, E., Seguro, L. P. C., & Borba, E. F. (2015) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1176-8 · Cited by 10
Antiphospholipid antibodies in chronic thromboembolic pulmonary hypertension
Zhu, R., Cheng, G.-Y., Denas, G., & Pengo, V. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.01.012 · Cited by 10
Association of HLA‐DQ alleles with the presence of an anti‐β2‐glycoprotein I antibody in patients with recurrent miscarriage
Chen, X., Liang, P., Li, G.-G., Diao, L., Liu, C., Huang, C., Wu, T., Xu, J., & Zeng, Y. (2015) · HLA · doi:10.1111/tan.12713 · Cited by 10
Assessment of vascular endothelial growth factor in systemic lupus erythematosus patients with anti-phospholipid syndrome
El-Gazzar, I. I., Ibrahim, S. E., El-Sawy, W. S., Fathi, H. M., & Eissa, A. H. (2018) · The Egyptian Rheumatologist · doi:10.1016/j.ejr.2018.03.005 · Cited by 10
Modulation of trophoblast function by concurrent hyperglycemia and antiphospholipid antibodies is in part TLR 4‐dependent
León-Martínez, D., Mulla, M. J., Han, C. S., Chamley, L., & Abrahams, V. M. (2018) · American Journal of Reproductive Immunology · doi:10.1111/aji.13045 · Cited by 10
Anti-β2GPI antibodies enhance atherosclerosis in ApoE-deficient mice
Wang, X., Zhu, X., Zhou, H., Xia, L., Wang, T., Wang, Z., Li, Y., Yan, J., & Wang, T. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.020 · Cited by 10
IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients
Sciascia, S., Cecchi, I., Radin, M., Rubini, E., Suárez, A., Roccatello, D., & Rodríguez‐Carrio, J. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00211 · Cited by 10
Impact of Antiphospholipid Syndrome on Reproductive Outcomes: Current Insights and Management Approaches
He, L., & Sims, C. A. (2024) · Seminars in Reproductive Medicine · doi:10.1055/s-0044-1790225 · Cited by 9
Can we use NOACS in APS?
Peleg, H., Naparstek, Y., Regola, F., Tincani, A., Pengo, V., & Denas, G. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102408 · Cited by 10
17β-Estradiol Promotes Proinflammatory and Procoagulatory Phenotype of Innate Immune Cells in the Presence of Antiphospholipid Antibodies
Manukyan, G. P., Martirosyan, A., Slavík, L., Úlehlová, J., Dihel, M., Papajík, T., & Kriegová, E. (2020) · Biomedicines · doi:10.3390/biomedicines8060162 · Cited by 9
Utilizing type I interferon expression in the identification of antiphospholipid syndrome subsets
Cecchi, I., Radin, M., Rodríguez‐Carrio, J., Tambralli, A., Knight, J. S., & Sciascia, S. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1901581 · Cited by 9
Recurrent arterial and venous thrombosis in a 16-year-old boy in the course of primary antiphospholipid syndrome despite treatment with low-molecular-weight heparin: a case report
Biernacka-Zielińska, M., Lipińska, J., Szymańska-Kałuża, J., Stańczyk, J., & Smolewska, E. B. (2013) · Journal of Medical Case Reports · doi:10.1186/1752-1947-7-221 · Cited by 9
Serum of patients with antiphospholipid syndrome induces adhesion molecules in endothelial cells
Engel, B., Müller, G. M., Roch, B., Schröder, H.-E., Aringer, M., Bornstein, S. R., & Morawietz, H. (2017) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2017.05.039 · Cited by 9
Difficulties in the Treatment of Recurring Diffuse Alveolar Hemorrhage Accompanying Primary Antiphospholipid Syndrome: A Case Report and Literature Review
Janowiak, P., Siemińska, A., Porzezińska, M., Smoleńska, Ż., Suchanek, H., & Jassem, E. (2018) · Advances in respiratory medicine · doi:10.5603/arm.2018.0020 · Cited by 9
Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome
Arora, S., Nair, S., Prabhu, R. R., Avanthika, C., Jhaveri, S., Samayam, S., Katta, M. R., & Agarwal, P. (2021) · Cureus · doi:10.7759/cureus.19009 · Cited by 10
A retrospective study on IVF/ICSI outcomes in patients with persisted positive of anticardiolipin antibody: Effects of low-dose aspirin plus low molecular weight heparin adjuvant treatment
Zhang, Y., Song, X., Xia, X., Wang, J., Qian, Y., Yuan, C., Mao, Y., Diao, F., Liu, J., & Ma, X. (2022) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2022.103674 · Cited by 9
An A1–A1 mutant with improved binding and inhibition of β2 GPI /antibody complexes in antiphospholipid syndrome
Kolyada, A. Y., Karageorgos, I. L., Mahlawat, P., & Beglova, N. (2014) · FEBS Journal · doi:10.1111/febs.13185 · Cited by 9
Interpretación de los autoanticuerpos en enfermedades reumatológicas
Méndez‐Rayo, T., Ochoa-Zárate, L., Posso‐Osorio, I., Ortíz, E., Naranjo-Escobar, J., & Tobón, G. J. (2018) · Revista Colombiana de Reumatología · doi:10.1016/j.rcreu.2018.02.004 · Cited by 9
Anti-domain 1 of beta2-glycoprotein I aids risk stratification in lupus anticoagulant-positive patients
Guo, H., Zhang, Y., Li, A., Wang, C., Yang, S., Zhang, Y., Zhang, J., & Qiao, R. (2019) · Clinical and Experimental Medicine · doi:10.1007/s10238-019-00555-w · Cited by 9
Understanding the structure of β2-glycoprotein I: new insights and future paths for antiphospholipid syndrome
Kumar, S., & Pozzi, N. (2024) · Blood Vessels Thrombosis & Hemostasis · doi:10.1016/j.bvth.2024.100041 · Cited by 8
Thrombophilia Testing in Venous Thromboembolism
Vrotniakaite-Bajerciene, K., Angelillo‐Scherrer, A., & Castellucci, L. A. (2025) · Medical Clinics of North America · doi:10.1016/j.mcna.2025.01.008 · Cited by 10
Optimization of Unnickedβ2-Glycoprotein I and High Avidity Anti-β2-Glycoprotein I Antibodies Isolation
Artenjak, A., Leonardi, A., Križaj, I., Ambrožič, A., Sodin‐Šemrl, S., Božič, B., & Čučnik, S. (2014) · Journal of Immunology Research · doi:10.1155/2014/195687 · Cited by 8
Autoantibody response and pregnancy-related pathology induced by combined LPS and tetanus toxoid hyperimmunization in BALB/c and C57BL/6 mice
Petrušić, V., Todorović, N., Zivkovic, I. P., Dimitrijević, R., Muhandes, L., Rajnpreht, I., & Dimitrijević, L. (2014) · Autoimmunity · doi:10.3109/08916934.2014.961061 · Cited by 8
Antiphospholipid and antioangiogenic activity in females with recurrent miscarriage and antiphospholipid syndrome
Pelusa, H. F., Pezzarini, E., Basiglio, C. L., Musuruana, J. L., Bearzotti, M., Svetaz, M. J., Daniele, S. M., Bottai, H., & Arriaga, S. M. M. (2016) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563216672248 · Cited by 8
Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis
Sciascia, S., Radin, M., Cecchi, I., Fenoglio, R., Marchi, A. D., Besso, L., Baldovino, S., Rossi, D., Miraglia, P., Rubini, E., et al. (2020) · Journal of Nephrology · doi:10.1007/s40620-019-00698-9 · Cited by 8
Inhibitor Index in the Clot Waveform Analysis-Based Mixing Test Differentiates among Hemophilia A without and with Inhibitors, and Lupus Anticoagulant
Shimonishi, N., Ogiwara, K., Oda, Y., Kawabe, T., Emmi, M., Shima, M., & Nogami, K. (2021) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1721776 · Cited by 8
Monoclonal antibody 26 cross-reactive with β2-glycoprotein I affects human trophoblast invasion in vitro
Kovačević, T. M., Radojčić, L., Tos̆ić, N., Pavlović, S., & Vićovac, L. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.08.005 · Cited by 8
Antiphospholipid Antibodies in Iraqi Women with Recurrent Mid-Trimester Abortions
Al-Samarrai, A. A., Hilmi, F. A., Al-Allawi, N. A. S., & Murad, A. F. (2012) · Journal of Laboratory Physicians · doi:10.4103/0974-2727.105586 · Cited by 8
IMMUNOREGULATORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS
Selkov, S. А., Соколов, Д. И., & Chepanov, S. V. (2014) · Medical Immunology (Russia) · doi:10.15789/1563-0625-2013-1-5-12 · Cited by 8
Laboratory Tests for the Antiphospholipid Syndrome
Pericleous, C., Ripoll, V. M., Giles, I., & Ioannou, Y. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0326-9_17 · Cited by 8
Syndrome catastrophique des antiphospholipides (CAPS) : revue 2016
Costedoat-Chalumeau, N., Coutte, L., Guern, V. L., Morel, N., Leroux, G., Paule, R., Mouthon, L., & Pietté, J. C. (2016) · La Presse Médicale · doi:10.1016/j.lpm.2016.07.023 · Cited by 8
“APS pregnancy – The offspring”
Bitsadze, V., Nalli, C., Khizroeva, J. K., Lini, D., Andréoli, L., Lojacono, A., Fazzi, E. M., Shoenfeld, Y., Tincani, A., & Makatsariya, A. D. (2020) · Lupus · doi:10.1177/0961203320947154 · Cited by 10
Identifying Additional Risk Factors for Thrombosis and Pregnancy Morbidities Among Antiphospholipid Antibodies Carriers
Zuo, Y., Fan, J., Sarode, R., Zhang, S., Makris, U. E., Karp, D. R., & Shen, Y.-M. (2018) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029618755946 · Cited by 7
Anti-GalNAcβ: A novel anti-glycan autoantibody associated with pregnancy loss in women with antiphospholipid syndrome and in a mouse experimental model
Blank, M., Krause, I., Dotan, N., Anafi, L., Eisenstein, M., Cervera, R., Meroni, P. L., & Shoenfeld, Y. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.07.002 · Cited by 7
Self-citation
Changes of platelet count throughout pregnancy in women with antiphospholipid syndrome
Mayer-Pickel, K. I., Stern, C., Eberhard, K., Lang, U., & Cervar-Zivkovic, M. (2019) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2019.102612 · Cited by 7
Profile and clinical relevance of non-criteria antiphospholipid antibodies in patients diagnosed with or highly suspected of APS
Li, S., Zhao, J., Bai, Y., Meng, J., Wang, Q., Tian, X., Li, M., Zeng, X., & Hu, C. (2023) · Rheumatology · doi:10.1093/rheumatology/kead303 · Cited by 8
Effect of smoking on thrombotic antiphospholipid syndrome: a 10-year prospective cohort study
Jiang, H., Huang, C. L., Shi, Y., Wang, C.-H., Chen, S., Li, J., Wang, Q., Li, M., Tian, X., Zeng, X., et al. (2023) · Rheumatology · doi:10.1093/rheumatology/kead498 · Cited by 7
Increased heterogeneity of brain perfusion is an early marker of central nervous system involvement in antiphospholipid antibody carriers
Lin, T., Hsu, P.-Y., Chang, C., Ko, C., Kuo, Y., Wu, Y., Yen, R., Wu, C.-H., Li, K., Hsein, Y.-C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182344 · Cited by 7
Estrés oxidativo en células endoteliales inducido por el suero de mujeres con diferentes manifestaciones clínicas del síndrome antifosfolípido
Velásquez, M., Granada, M. A., Galvis, J. C., Álvarez, Á. M., & Cadavid, Á. P. (2019) · Biomédica · doi:10.7705/biomedica.4701 · Cited by 7
Elevated IgA antiphospholipid antibodies in healthy pregnant women in Sudan but not Sweden, without corresponding increase in IgA anti-β 2 glycoprotein I domain 1 antibodies
Elbagir, S., Mohammed, N. A., Kaihola, H., Svenungsson, E., Gunnarsson, I., Manivel, V. A., Pertsinidou, E., Elagib, E. M., Nur, M. A., Elussein, E. A., et al. (2020) · Lupus · doi:10.1177/0961203320908949 · Cited by 7
Anti-DNA antibodies cross-reactive with β2-glycoprotein I induce monocyte tissue factor through the TLR9 pathway
Saito, M., Makino, Y., Inoue, K., Watanabe, Y., Hoshi, O., & Kubota, T. (2020) · Immunological Medicine · doi:10.1080/25785826.2020.1796285 · Cited by 8
Association between plasmatic oxidative stress and thrombosis in primary antiphospholipid syndrome
Vaz, C. D. O., Mazetto, B. D. M., Vasconcelos, P. E. N. S., Bastos, L. B., Cursino, M. A., Quintanilha, J. C. F., Mesquita, G. L. T. V., dos Santos, A. P. R., Jacintho, B. C., Oliveira, J. D., et al. (2021) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-021-02509-0 · Cited by 7
Association between interferon-I producing plasmacytoid dendritic cells and thrombotic antiphospholipid syndrome
dos Santos, A. P. R., Vaz, C. D. O., Hounkpe, B. W., Jacintho, B. C., Oliveira, J. D., Mesquita, G. L. T. V., dos Santos, I. P., Annichino‐Bizzacchi, J. M., Appenzeller, S., Mazetto, B. D. M., et al. (2022) · Lupus · doi:10.1177/09612033221101731 · Cited by 7
Oxidatively altered IgG with increased immunoreactivity to β2-glycoprotein I and its peptide clusters influence human coronary artery endothelial cells
Artenjak, A., Omersel, J., Grabnar, P. A., Mlinarič‐Raščan, I., Shoenfeld, Y., Sodin-Semrl, S., Božič, B., & Čučnik, S. (2015) · Lupus · doi:10.1177/0961203314561073 · Cited by 7
Antiphospholipid Antibody Positivity and the Clinical Outcomes of Patients with Systemic Lupus Erythematosus
Nam, S. W., Cho, S., Kim, D., Lee, K.-E., Park, D.-J., Lee, S., & Sung, Y. (2018) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2018.25.4.239 · Cited by 7
Laboratory Assessment of Patients with Suspected Rheumatic Musculoskeletal Diseases: Challenges and Pitfalls
Carubbi, F., Alunno, A., Cipriani, P., Bistoni, O., Scipioni, R., Liakouli, V., Ruscitti, P., Berardicurti, O., Bartolomeo, S. D., Gerli, R., et al. (2018) · Current Rheumatology Reviews · doi:10.2174/1573397114666180320113603 · Cited by 7
Antiphospholipid Antibody Syndrome Presenting with Hemichorea
Ayalew, Y., & Khattak, F. (2012) · Case Reports in Rheumatology · doi:10.1155/2012/471543 · Cited by 7
The pivotal role of endothelial protein C receptor for antiphospholipid antibody-mediated pathologies
Chu, C. (2021) · Rheumatology · doi:10.1093/rheumatology/keab620 · Cited by 7
Understanding the difference between type I and type II antiprothrombin antibodies and their effect on activated protein C resistance
Pozzi, N., Pontara, E., Kumar, S., & Pengo, V. (2024) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2024.07.005 · Cited by 6
Domain and residue mapping of autoantibodies to β2GPI reveals differences among antiphospholipid syndrome phenotypes
Kumar, S., Vaid, D., Lonati, P. A., Via, A. D., Tonello, M., Meroni, P. L., Pengo, V., & Pozzi, N. (2025) · Blood · doi:10.1182/blood.2025029488 · Cited by 6
Self-citation
High Avidity Anti-β2-Glycoprotein i Antibodies Activate Human Coronary Artery Endothelial Cells and Trigger Peripheral Blood Mononuclear Cell Migration
Artenjak, A., Koželj, M., Lakota, K., Čučnik, S., Božič, B., & Sodin-Semrl, S. (2013) · European Journal of Inflammation · doi:10.1177/1721727x1301100209 · Cited by 6
Soluble LILRA3 is aberrantly expressed in antiphospholipid syndrome (APS) and is a potential marker of thrombotic APS
Liu, H., Li, C., Shi, H., Guo, Y., Tang, Y., Chen, C., Zhao, Z., Hoy, C. K., Yalavarthi, S., Figueroa‐Parra, G., et al. (2022) · Rheumatology · doi:10.1093/rheumatology/keac192 · Cited by 6
Atomistic characterization of β2-glycoprotein I domain V interaction with anionic membranes
Hasdemir, H. S., Pozzi, N., & Tajkhorshid, E. (2024) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2024.07.010 · Cited by 7
Clinical and Prognostic Significance of Non-criteria Antiphospholipid Antibody Tests
Bertolaccini, M. L., Amengual, O., Artim-Esen, B., Atsumi, T., de Groot, P. G., de Laat, B., Devreese, K. M. J., Giles, I., Meroni, P. L., Borghi, M. O., et al. (2017) · Springer eBooks · doi:10.1007/978-3-319-55442-6_8 · Cited by 6
Self-citation
A Simplified Understanding of the Black Swan: Anti-phospholipid Antibody Syndrome
Vaidya, B., Nakarmi, S., Joshi, R., & Baral, R. (2019) · Journal of Nepal Medical Association · doi:10.31729/jnma.4226 · Cited by 6
COVID-19 Infection and High Intracoronary Thrombus Burden
Kirresh, A. Z., Coghlan, G., & Candilio, L. (2020) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2020.07.032 · Cited by 6
Forecasting the Future of Antiphospholipid Syndrome: Prospects and Challenges.
Taylor, A., Kumar, S., & Pozzi, N. (2023) · PubMed Central · Cited by 6
Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis
Li, R., Daguzan, M., Vandermijnsbrugge, F., Gyling, M., & Cantinieaux, B. (2014) · Acta Clinica Belgica · doi:10.1179/2295333714y.0000000060 · Cited by 6
Genetics and Origin of Antiphospholipid Syndrome
Soriano, A., Blank, M., & Shoenfeld, Y. (2014) · Rare diseases of the immune system · doi:10.1007/978-3-319-11044-8_1 · Cited by 6
Multifocal avascular osteonecrosis despite appropriate anticoagulation therapy in a patient with systemic lupus erythematosus and antiphospholipid syndrome
Cecchi, I., Sánchez, L. P., Sciascia, S., & Roccatello, D. (2018) · BMJ Case Reports · doi:10.1136/bcr-2018-225532 · Cited by 6
COVID-19 coagulopathy and antiphospholipid syndrome
Serrano, M., Espinosa, G., Cervera, R., & Serrano, A. (2021) · Revista Colombiana de Reumatología · doi:10.1016/j.rcreu.2021.02.013 · Cited by 7
Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic review
Anunciación-Llunell, A., Miró‐Mur, F., Esteve‐Valverde, E., Marques-Soares, J. R., Pardos‐Gea, J., & Alijotas‐Reig, J. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102982 · Cited by 6
Complement inhibitory proteins expression in placentas of thrombophilic women
Wirstlein, P. K., Jasiński, P., Rajewski, M., Goździewicz, T., & Skrzypczak, J. (2012) · Folia Histochemica et Cytobiologica · doi:10.5603/19758 · Cited by 6
Methylenetetrahydrofolate Reductase 677T Allele Is a Risk Factor for Arterial Thrombosis in Chinese Han Patients with Antiphospholipid Syndrome
Tang, Z., Shi, H., Liu, H., Cheng, X., Su, Y., Ye, J., Sun, Y., Hu, Q., Chi, H., Zhou, Z., et al. (2022) · Biomedicines · doi:10.3390/biomedicines11010055 · Cited by 6
Approaches to Microthrombotic Wounds: A Review of Pathogenesis and Clinical Features
Mufti, A., Maliyar, K., Syed, M. F., Pagnoux, C., & Alavi, A. (2020) · Advances in Skin & Wound Care · doi:10.1097/01.asw.0000617860.92050.9e · Cited by 6
Beta-2 GPI induced tissue factor and placental apoptosis for the pathophysiology of pregnancy loss in antiphospholipid syndrome
Velayuthaprabhu, S., Matsubayashi, H., & Archunan, G. (2016) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20162267 · Cited by 5
New method to differentiate between lupus anticoagulants, progressive coagulation inhibitors and coagulation factor deficiencies in the mixing tests
Shimomura, D., Kumano, O., Ueda, K., Kitano, K., Arai, N., Shimada, M., & Kamioka, M. (2024) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.14289 · Cited by 5
Establishment of ELISA-comparable moderate and high thresholds for anticardiolipin and anti-β2 glycoprotein I chemiluminescent immunoassays according to the 2023 ACR/EULAR APS classification criteria and evaluation of their diagnostic performance
Žigon, P., Boštic, N., Ambrožič, A., Rotar, Ž., Blokar, E., Ogrič, M., & Čučnik, S. (2024) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2024-0570 · Cited by 5
Summary of the 9th meeting of the European Forum on Antiphospholipid Antibodies
Swadźba, J., Sydor, W., Kołodziejczyk, J., & Musiał, J. (2014) · Lupus · doi:10.1177/0961203314520841 · Cited by 5
Distinct features of youth-onset primary antiphospholipid syndrome
Baleeiro, C., Duran, C. S., Signorelli, F., Balbi, G. G. M., Bonfá, E., & Andrade, D. C. O. (2021) · Lupus · doi:10.1177/09612033211038054 · Cited by 5
Shared features of pathogenetic aspects, autoimmunity and pharmacotherapy in coronavirus infection (COVID-19) and immunoinflammatory rheumatic diseases
Rutskaya-Moroshan, K., Abisheva, S., & Lila, A. M. (2022) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2022-5-82-87 · Cited by 5
Lupus anticoagulant laboratory diagnosis by applying the 2020 ISTH-SSC guidelines
Talon, L., Fourneyron, V., Senectaire, S., Tardieu, M., Tillier, M., Trapani, A., Trayaud, A., Vaissade, A., Sapin, A.-F. S., Lebreton, A., et al. (2023) · Thrombosis Research · doi:10.1016/j.thromres.2023.02.009 · Cited by 6
Presumed antiphospholipid syndrome and thrombotic thrombocytopenic purpura: An infrequent association
Dolin, H. H., Dziuba, M., Pappada, S. M., & Papadimos, T. J. (2019) · Clinical Case Reports · doi:10.1002/ccr3.2416 · Cited by 5
Proteomic Analysis of Differentially Expressed Proteins in the Placenta of Anticardiolipin Antibody‐ (ACA‐) Positive Pregnant Mice after Anzi Heji Treatment
Xie, Y., & Lu, Q. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/1967698 · Cited by 5
Self-perceived quality of life of primary antiphospholipid syndrome patients using vitamin K antagonist
Vaz, C. D. O., Mazetto, B. D. M., Vasconcelos, P. E. N. S., Bastos, L. B., Cursino, M. A., Quintanilha, J. C. F., Mesquita, G. L. T. V., dos Santos, A. P. R., Jacintho, B. C., Oliveira, J. D., et al. (2021) · Lupus · doi:10.1177/0961203321990079 · Cited by 5

Authors: Meroni, P. L., Borghi, M. O., Raschi, E., & Tedesco, F.
Affiliations: University of Milan (IT)
IRCCS Istituto Auxologico Italiano (IT)
University of Trieste (IT)
Corresponding author: Meroni, Pier Luigi
ORCID: Meroni, Pier Luigi
Borghi, M. Orietta
Raschi, Elena
Tedesco, Francesco
Venue: Nature Reviews Rheumatology
Publisher: Springer Science and Business Media LLC
Published: 2011-05-10
Volume: 7
Issue: 6
Pages: 330-339
ISSN: 1759-4790 (ISSN-L)
1759-4804
DOI: 10.1038/nrrheum.2011.52
OpenAlex: W1999555834
Cited by: 620
References: 89
Citations by year: 2026: 38 · 2025: 34 · 2024: 35 · 2023: 34 · 2022: 39 · 2021: 47 · 2020: 34 · 2019: 41 · 2018: 43 · 2017: 43 · 2016: 54 · 2015: 33 · 2014: 63 · 2013: 37 · 2012: 36
FWCI: 6.72
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Reviews Rheumatology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords: antiphospholipid syndrome, antiphospholipid antibodies, beta2-glycoprotein I, thrombosis, recurrent pregnancy loss, placental inflammation, trophoblast differentiation, complement activation, innate immune response, autoantibody pathogenesis
MeSH terms: Female, Humans, Pregnancy, Pregnancy Complications, Antiphospholipid Syndrome, Antibodies, Antiphospholipid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks